Explore Cell Therapy

08 - Returning to Work Post-HCT, Pt. 2: Communication and Resources to Overcome Barriers

In this two-part episode, Rachel Salit, MD, with Fred Hutch Cancer Center and Katie Schoeppner, MSW, of NMDP/Be The Match, discuss their recently developed evidence-based guidance for health care providers to assist patients in returning to work after hematopoietic cell transplantation as part of a committee of the American Society for Transplantation and Cellular Therapy (ASTCT).
In Part II: Communication and Resources to Overcome Barriers, experts dive deeper into the importance of multidisciplinary collaboration and communication across the care team, as well as resources to overcome barriers and evidence-based approaches to help patients return to work.
To read bios on the panelists and to access additional resources related to this episode, visit Our Site. 

08 – Returning to Work Post-HCT, Pt. 1: Guidance Development and Challenges

In this two-part episode, Rachel Salit, MD, with Fred Hutch Cancer Center and Katie Schoeppner, MSW, of NMDP/Be The Match, discuss their recently developed evidence-based guidance for health care providers to assist patients in returning to work after hematopoietic cell transplantation as part of a committee of the American Society for Transplantation and Cellular Therapy (ASTCT).
In Part I: Guidance Development and Challenges, experts explore the complex challenges transplant patients face when returning to work and major findings from their evidence-based review, including the importance of appropriate accommodations, early communication with employers, and patient-reported outcomes.
To read bios on the panelists and to access additional resources related to this episode, visit Our Site. 

07 - HCT Practice Guidelines for MDS, Pt. 2: Increasing Access and Shared Care

In this two-part episode, Zachariah DeFilipp, MD, and Andrew Brunner, MD, with Massachusetts General Hospital discuss their findings on a committee of the American Society for Transplantation and Cellular Therapy (ASTCT) to publish an evidence-based review on guidelines for the use of allogeneic hematopoietic cell transplantation in the management and treatment of myelodysplastic syndromes (MDS) from the perspective of both transplant and hematology/oncology.
In Part II: Increasing Access and Shared Care, experts share insights into MDS treatment to assist both hematology/oncology practices and transplant centers in improving HCT access through shared care, especially for older patients with MDS.
To read bios on the panelists and to access additional resources related to this episode, visit Our Site. 

07 - HCT Practice Guidelines for MDS, Pt. 1: Risk Stratification and Eligibility

In this two-part episode, Zachariah DeFilipp, MD, and Andrew Brunner, MD, with Massachusetts General Hospital discuss their findings on a committee of the American Society for Transplantation and Cellular Therapy (ASTCT) to publish an evidence-based review on guidelines for the use of allogeneic hematopoietic cell transplantation in the management and treatment of myelodysplastic syndromes (MDS) from the perspective of both transplant and hematology/oncology.
In Part I: Risk Stratification and Eligibility, experts discuss the goals of the guidelines review, the latest research, advances in MDS risk stratification and eligibility criteria, and best practices for patients with different presentations of MDS.
To read bios on the panelists and to access additional resources related to this episode, visit Our Site. 

06 – Overcoming Challenges in Cell & Gene Therapy Clinical Trials, Pt. 2: Cost and Collaboration

This two-part episode features a panel discussion from Advanced Therapies Week 2023, a conference focused on advancing cell and gene therapy. In a session sponsored by Be The Match BioTherapies® and moderated by Chris McClain, MBA, Heather Stefanski, MD, PhD, Erin Leckrone, MBA, and Gabbi Giammarino, BS, discuss the current state of the cell and gene therapy industry to ramp up clinical trials and expand access to care.  In Part 2: Cost and Collaboration, experts explore cost considerations in clinical trials and what to look for in a research partner to ensure trial success.
To read bios on the panelists and to access additional resources related to this episode, visit Our Site. 

06 – Overcoming Challenges in Cell & Gene Therapy Clinical Trials, Pt. 1: Study Design and Recruitment

This two-part episode features a panel discussion from Advanced Therapies Week 2023, a conference focused on advancing cell and gene therapy. In a session sponsored by Be The Match BioTherapies® and moderated by Chris McClain, MBA, Heather Stefanski, MD, PhD, Erin Leckrone, MBA, and Gabbi Giammarino, BS, discuss the current state of the cell and gene therapy industry to ramp up clinical trials and expand access to care.  In Part 1: Study Design and Recruitment, experts examine what’s currently happening in the industry and the biggest challenges facing clinical trial design, recruitment, and management.
To read bios on the panelists and to access additional resources related to this episode, visit Our Site. 

05 - State of the Science in Ensuring a Donor for All, Pt. 2: Donor Optimization and Looking to the Future

In this two-part episode, Stephen Spellman, MBS, and Jeffrey Auletta, MD, with the National Marrow Donor Program®/Be The Match® and the CIBMTR® (Center for International Blood and Marrow Transplantation Research) discuss the current state of the science in finding an optimal donor for all patients in need of allogeneic hematopoietic cell transplantation.
In Part II: Donor Optimization and Looking into the Future, experts share the opportunity to close equity gaps, optimize donor selection, and further expand access to transplant.
To read bios on the panelists and to access additional resources related to this episode, visit Our Site. 

05 - State of the Science in Ensuring a Donor for All, Pt. 1: Donor Availability and Addressing Barriers

In this two-part episode, Stephen Spellman, MBS, and Jeffrey Auletta, MD, with the National Marrow Donor Program®/Be The Match® and the CIBMTR® (Center for International Blood and Marrow Transplantation Research) discuss the current state of the science in finding an optimal donor for all patients in need of allogeneic hematopoietic cell transplantation.
In Part I: Donor Availability and Addressing Barriers, experts explore advances that have improved donor availability and how barriers can be addressed for patients in need of transplant.
To read bios on the panelists and to access additional resources related to this episode, visit Our Site. 

04 – Structural Racism and AML, Pt. 2: Addressing Barriers and Equity Across Healthcare Teams

In this two-part episode, Irum Khan, MD, of University of Illinois Chicago and Jonathan Moreira, MD, of Northwestern University explore novel research on the impact of structural racism on acute myeloid leukemia (AML) outcomes for underserved communities and ethnically diverse patients in the Chicago area. In Part II: Addressing Barriers and Equity Across Healthcare Teams, guests examine solutions to improve access and address barriers to care, emphasizing policy reform and the importance of strong provider relationships across the patient’s transplant journey. For more information, research and resources from this episode, or full bios of our guests, visit our site.
To read bios on the panelists and to access additional resources related to this episode, visit Our Site. 

04 – Structural Racism and AML, Pt. 1: The Impact of Structural Racism on AML Outcomes

In this two-part episode, Irum Khan, MD, of University of Illinois Chicago and Jonathan Moreira, MD, of Northwestern University explore novel research on the impact of structural racism on acute myeloid leukemia (AML) outcomes for underserved communities and ethnically diverse patients in the Chicago area. In Part I: The Impact of Structural Racism on AML Outcomes, Dr. Khan shares findings from her eye-opening research and examines implications on health disparities and barriers to care for ethnically diverse patients through discussion with Dr. Moreira. For more information, research and resources from this episode, or full bios of our guests, visit our site.
To read bios on the panelists and to access additional resources related to this episode, visit Our Site.